1Kornstein S G, Schneider R K. Clinical features of treatment depression[J].J Clin Psychiatry,2001,62(Suppl 16):18-25.
2Culpepper L. Early onset of antidepressant action impact on primary care[J].J Clin Psychiatry, 2001,62(Suppl 4):4-6.
3Svensson T H. Brain noradrenaline and the mechanism of action of antidepression drugs[J]. Acta Psychiat Scand, 2000,101(Suppl,402):18-27.
4Blier P. Possible neurobiological mechanism underlying faster onset of antidepressant action[J]. J Clin Psychiatry, 2001,62(Suppl 4):7-11.
5Lenox R H, Hahn C G. Overview of the mechanism of action of lithium in the brain,fifty-year update[J]. J Clin Psychiatry, 2000,61(Suppl 9):5-15.
6Blier P. Pharmacology of rapid-onset antidepressant treatment strategies[J]. J Clin Psychiatry, 2001,62(Suppl 15):12-17.
7Nierenberg A A. Do some antidepressant work faster than others[J]? J Clin Psychiatry, 2001,62(Suppl 15):22-25.
8Stahl S, Nierenberg A A, Gorman J M. Evidence of early onset of antidepressant effect in randomized controlled trials[J]. J Clin Psychiatry, 2001,62(Suppl 4):17-23.
9Keller M B, Pinder R M. The role of mirtazapine in the pharmacotherapy of depression[J]. J Clin Psychiatry, 2000,61:609-616.
10Gumnick J F, Nemeroff C B. Problems with currently available antidepressants[J]. J Clin Psychiatry, 2000,61(suppl 10):5-15.
同被引文献10
1Crossley NA, Bauer M. Acceleration and angraentation of antide- pressants with lithium for depressive disorders[ J]. Journal of Clini- cal Psychiatry,2007,68 ( 6 ) : 935-940.
2Appdberg BG,Syvalahti EK, Koskinen TE, et al. Patients with se- vere depression may benefit from buspirone augmentation of selec- tive serotonin reuptake inhibitors: results from a placebo-con- trolled, randomized, double-blind, placebo wash-in study [ J ]. J Clin Psychiatry ,2001,62(6) :448-452.
3Land6n M, Bjtirling G, Agren H, et al. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression [ J ]. J Clin Psychia-try, 1998,59 ( 12 ) :664-668.
4Machado-Vieira R, Baumann J, Wheeler-Castillo C, et al. The tim- ing of antidepressant effects : a comparison of diverse pharmacologi- cal and somatic treatments[ J ]. Pharmaceuticals, 2010,3 ( 1 ) : 19- 41.
5Blier P, Bergeron R, De Montigny C. Selective activation of posts- ynaptic 5-HTIA receptors induces rapid antidepressant response [ J ]. Neuropsychopharmacology, 1997,16 ( 5 ) :333-338.
6Gobert A, Rivet JM, CistareUi L, et al. Buspirone modulates basal dialysate levels of dopamine, noradrena- line and serotonin in the frontal cortex of freely moving rats:activa- tion of serotonin 1 A receptors and blockade of ct 2-adrenergic re- ceptors underlie its actions [ J ]. Neuroscience, 1999,93 (4) : 1251- 1262.
7Meltzer HY, Flemming R, Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man [ J ]. Arch Gen Psychiatry, 1983,40 (10) : 1099-1102.
